Announcement • 15h
MT Genex Corporation (TSE:9820) agreed to acquire Next Inc. for ¥1.8 billion. MT Genex Corporation (TSE:9820) agreed to acquire Next Inc. for ¥1.8 billion on July 21, 2026. A cash consideration will be paid by MT Genex Corporation. As part of consideration, an undisclosed value is paid towards common equity of Next Inc.
For the period ending October 31, 2025, Next Inc. reported total revenue of ¥1.61 billion, EBIT of ¥125 million and net income of ¥129 million. As of October 31, 2025, Next Inc. reported total assets of ¥1.29 billion and total common equity of ¥1.03 billion.
The transaction is approved by acquirer board. The expected completion of the transaction is July 31, 2026. Announcement • May 29
MT Genex Corporation to Report Q1, 2027 Results on Aug 07, 2026 MT Genex Corporation announced that they will report Q1, 2027 results on Aug 07, 2026 Reported Earnings • May 13
Full year 2026 earnings released: EPS: JP¥292 (vs JP¥245 in FY 2025) Full year 2026 results: EPS: JP¥292 (up from JP¥245 in FY 2025). Revenue: JP¥4.71b (up 19% from FY 2025). Net income: JP¥314.0m (up 19% from FY 2025). Profit margin: 6.7% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 11
MT Genex Corporation, Annual General Meeting, Jun 23, 2026 MT Genex Corporation, Annual General Meeting, Jun 23, 2026. Announcement • May 10
MT Genex Corporation to Report Fiscal Year 2026 Results on May 11, 2026 MT Genex Corporation announced that they will report fiscal year 2026 results on May 11, 2026 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥40.00 per share Eligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.4%). Buy Or Sell Opportunity • Mar 03
Now 21% undervalued Over the last 90 days, the stock has risen 18% to JP¥4,050. The fair value is estimated to be JP¥5,100, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.9% over the last 3 years, while earnings per share has been flat. Valuation Update With 7 Day Price Move • Feb 26
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to JP¥4,140, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 14x in the Construction industry in Japan. Total returns to shareholders of 86% over the past three years. Reported Earnings • Feb 07
Third quarter 2026 earnings released: EPS: JP¥94.72 (vs JP¥48.28 in 3Q 2025) Third quarter 2026 results: EPS: JP¥94.72 (up from JP¥48.28 in 3Q 2025). Revenue: JP¥1.18b (up 31% from 3Q 2025). Net income: JP¥102.0m (up 96% from 3Q 2025). Profit margin: 8.7% (up from 5.8% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Buy Or Sell Opportunity • Dec 15
Now 20% undervalued Over the last 90 days, the stock has risen 4.9% to JP¥3,425. The fair value is estimated to be JP¥4,300, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has grown by 3.2%. Announcement • Nov 29
MT Genex Corporation to Report Q3, 2026 Results on Feb 06, 2026 MT Genex Corporation announced that they will report Q3, 2026 results on Feb 06, 2026 Buy Or Sell Opportunity • Nov 28
Now 20% undervalued Over the last 90 days, the stock has risen 6.4% to JP¥3,425. The fair value is estimated to be JP¥4,294, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has grown by 3.2%. Buy Or Sell Opportunity • Nov 11
Now 21% undervalued Over the last 90 days, the stock has risen 8.5% to JP¥3,450. The fair value is estimated to be JP¥4,343, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has grown by 3.2%. Reported Earnings • Nov 09
Second quarter 2026 earnings released: EPS: JP¥61.32 (vs JP¥73.45 in 2Q 2025) Second quarter 2026 results: EPS: JP¥61.32 (down from JP¥73.45 in 2Q 2025). Revenue: JP¥1.13b (up 10% from 2Q 2025). Net income: JP¥66.0m (down 17% from 2Q 2025). Profit margin: 5.9% (down from 7.7% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Buy Or Sell Opportunity • Oct 27
Now 20% undervalued Over the last 90 days, the stock has risen 16% to JP¥3,500. The fair value is estimated to be JP¥4,383, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.9% over the last 3 years. Earnings per share has grown by 3.3%. Buy Or Sell Opportunity • Oct 07
Now 20% undervalued Over the last 90 days, the stock has risen 18% to JP¥3,520. The fair value is estimated to be JP¥4,414, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.9% over the last 3 years. Earnings per share has grown by 3.3%. Announcement • Sep 01
MT Genex Corporation to Report Q2, 2026 Results on Nov 07, 2025 MT Genex Corporation announced that they will report Q2, 2026 results on Nov 07, 2025 Reported Earnings • Aug 11
First quarter 2026 earnings released: EPS: JP¥38.09 (vs JP¥31.59 in 1Q 2025) First quarter 2026 results: EPS: JP¥38.09 (up from JP¥31.59 in 1Q 2025). Revenue: JP¥976.0m (up 14% from 1Q 2025). Net income: JP¥41.0m (up 21% from 1Q 2025). Profit margin: 4.2% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 11% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Jul 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 2 highly experienced directors. Independent Outside Director Kazuyasu Abe was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • May 31
MT Genex Corporation to Report Q1, 2026 Results on Aug 08, 2025 MT Genex Corporation announced that they will report Q1, 2026 results on Aug 08, 2025 Reported Earnings • May 14
Full year 2025 earnings released: EPS: JP¥245 (vs JP¥257 in FY 2024) Full year 2025 results: EPS: JP¥245 (down from JP¥257 in FY 2024). Revenue: JP¥3.95b (up 4.2% from FY 2024). Net income: JP¥264.0m (down 4.7% from FY 2024). Profit margin: 6.7% (down from 7.3% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 7% per year. Announcement • May 12
MT Genex Corporation, Annual General Meeting, Jun 24, 2025 MT Genex Corporation, Annual General Meeting, Jun 24, 2025. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥40.00 per share Eligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.7%). Lower than average of industry peers (3.3%). Announcement • Mar 01
MT Genex Corporation to Report Fiscal Year 2025 Results on May 12, 2025 MT Genex Corporation announced that they will report fiscal year 2025 results on May 12, 2025 Reported Earnings • Feb 08
Third quarter 2025 earnings released: EPS: JP¥48.28 (vs JP¥86.43 in 3Q 2024) Third quarter 2025 results: EPS: JP¥48.28 (down from JP¥86.43 in 3Q 2024). Revenue: JP¥898.0m (down 3.5% from 3Q 2024). Net income: JP¥52.0m (down 44% from 3Q 2024). Profit margin: 5.8% (down from 10.0% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 5% per year. Announcement • Dec 03
MT Genex Corporation to Report Q3, 2025 Results on Feb 07, 2025 MT Genex Corporation announced that they will report Q3, 2025 results on Feb 07, 2025 Reported Earnings • Nov 11
Second quarter 2025 earnings released: EPS: JP¥73.40 (vs JP¥69.70 in 2Q 2024) Second quarter 2025 results: EPS: JP¥73.40 (up from JP¥69.70 in 2Q 2024). Revenue: JP¥1.02b (down 5.8% from 2Q 2024). Net income: JP¥79.0m (up 5.3% from 2Q 2024). Profit margin: 7.7% (up from 6.9% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has fallen by 1% per year. Announcement • Aug 27
MT Genex Corporation to Report Q2, 2025 Results on Nov 08, 2024 MT Genex Corporation announced that they will report Q2, 2025 results on Nov 08, 2024 Reported Earnings • Aug 11
First quarter 2025 earnings released: EPS: JP¥31.59 (vs JP¥79.00 in 1Q 2024) First quarter 2025 results: EPS: JP¥31.59 (down from JP¥79.00 in 1Q 2024). Revenue: JP¥856.0m (down 8.6% from 1Q 2024). Net income: JP¥34.0m (down 60% from 1Q 2024). Profit margin: 4.0% (down from 9.1% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. New Risk • Aug 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥2.37b market cap, or US$16.6m). Buy Or Sell Opportunity • Aug 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 21% to JP¥2,201. The fair value is estimated to be JP¥2,803, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.5% over the last 3 years. Earnings per share has grown by 9.1%. Announcement • Jun 10
MT Genex Corporation to Report Q1, 2025 Results on Aug 09, 2024 MT Genex Corporation announced that they will report Q1, 2025 results on Aug 09, 2024 Reported Earnings • May 17
Full year 2024 earnings released: EPS: JP¥257 (vs JP¥224 in FY 2023) Full year 2024 results: EPS: JP¥257 (up from JP¥224 in FY 2023). Revenue: JP¥3.79b (up 16% from FY 2023). Net income: JP¥277.0m (up 15% from FY 2023). Profit margin: 7.3% (down from 7.4% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Announcement • May 15
MT Genex Corporation, Annual General Meeting, Jun 25, 2024 MT Genex Corporation, Annual General Meeting, Jun 25, 2024. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥40.00 per share Eligible shareholders must have bought the stock before 28 March 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of Japanese dividend payers (3.2%). Lower than average of industry peers (2.7%). Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to JP¥3,040, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 13x in the Construction industry in Japan. Total returns to shareholders of 17% over the past three years. Announcement • Mar 02
MT Genex Corporation to Report Fiscal Year 2024 Results on May 13, 2024 MT Genex Corporation announced that they will report fiscal year 2024 results on May 13, 2024 Reported Earnings • Feb 11
Third quarter 2024 earnings released: EPS: JP¥86.32 (vs JP¥69.70 in 3Q 2023) Third quarter 2024 results: EPS: JP¥86.32 (up from JP¥69.70 in 3Q 2023). Revenue: JP¥931.0m (up 5.8% from 3Q 2023). Net income: JP¥93.0m (up 24% from 3Q 2023). Profit margin: 10.0% (up from 8.5% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 3% per year. Announcement • Dec 15
MT Genex Corporation (TSE:9820) agreed to acquire Itec Ltd. from Yasushi Ide. MT Genex Corporation (TSE:9820) agreed to acquire Itec Ltd. from Yasushi Ide on November 2023. Itec Ltd reported Total revenue of KRW 622 million, Total assets of KRW 444 million, EBIT of KRW 20 million, Net Income of KRW 42 million and Total common equity of KRW 292 million on Fiscal year ending May 2023. Announcement • Nov 30
MT Genex Corporation to Report Q3, 2024 Results on Feb 09, 2024 MT Genex Corporation announced that they will report Q3, 2024 results on Feb 09, 2024 Reported Earnings • Nov 12
Second quarter 2024 earnings released: EPS: JP¥69.64 (vs JP¥27.88 in 2Q 2023) Second quarter 2024 results: EPS: JP¥69.64 (up from JP¥27.88 in 2Q 2023). Revenue: JP¥1.08b (up 59% from 2Q 2023). Net income: JP¥75.0m (up 150% from 2Q 2023). Profit margin: 6.9% (up from 4.4% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year. Announcement • Sep 16
MT Genex Corporation to Report Q2, 2024 Results on Nov 10, 2023 MT Genex Corporation announced that they will report Q2, 2024 results on Nov 10, 2023 Reported Earnings • Aug 08
First quarter 2024 earnings released: EPS: JP¥78.96 (vs JP¥59.48 in 1Q 2023) First quarter 2024 results: EPS: JP¥78.96 (up from JP¥59.48 in 1Q 2023). Revenue: JP¥937.0m (up 12% from 1Q 2023). Net income: JP¥85.0m (up 33% from 1Q 2023). Profit margin: 9.1% (up from 7.7% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Announcement • Jun 03
MT Genex Corporation to Report Q1, 2024 Results on Aug 07, 2023 MT Genex Corporation announced that they will report Q1, 2024 results on Aug 07, 2023 Reported Earnings • May 16
Full year 2023 earnings released: EPS: JP¥224 (vs JP¥197 in FY 2022) Full year 2023 results: EPS: JP¥224 (up from JP¥197 in FY 2022). Revenue: JP¥3.26b (up 9.9% from FY 2022). Net income: JP¥241.0m (up 14% from FY 2022). Profit margin: 7.4% (up from 7.1% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Announcement • May 14
MT Genex Corporation, Annual General Meeting, Jun 27, 2023 MT Genex Corporation, Annual General Meeting, Jun 27, 2023. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥40.00 per share at 1.7% yield Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (3.6%). Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: JP¥69.61 (vs JP¥51.12 in 3Q 2022) Third quarter 2023 results: EPS: JP¥69.61 (up from JP¥51.12 in 3Q 2022). Revenue: JP¥880.0m (up 24% from 3Q 2022). Net income: JP¥75.0m (up 36% from 3Q 2022). Profit margin: 8.5% (up from 7.7% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 15% per year. Announcement • Dec 02
MT Genex Corporation to Report Q3, 2023 Results on Feb 10, 2023 MT Genex Corporation announced that they will report Q3, 2023 results on Feb 10, 2023 Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Kazuyasu Abe was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 13
Second quarter 2023 earnings released: EPS: JP¥27.86 (vs JP¥75.28 in 2Q 2022) Second quarter 2023 results: EPS: JP¥27.86 (down from JP¥75.28 in 2Q 2022). Revenue: JP¥681.0m (down 17% from 2Q 2022). Net income: JP¥30.0m (down 63% from 2Q 2022). Profit margin: 4.4% (down from 9.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 13% per year. Announcement • Aug 28
MT Genex Corporation to Report Q2, 2023 Results on Nov 11, 2022 MT Genex Corporation announced that they will report Q2, 2023 results on Nov 11, 2022 Valuation Update With 7 Day Price Move • Aug 23
Investor sentiment improved over the past week After last week's 24% share price gain to JP¥2,783, the stock trades at a trailing P/E ratio of 12.6x. Average trailing P/E is 9x in the Construction industry in Japan. Total loss to shareholders of 26% over the past three years. Reported Earnings • Aug 07
First quarter 2023 earnings released: EPS: JP¥59.45 (vs JP¥35.32 in 1Q 2022) First quarter 2023 results: EPS: JP¥59.45 (up from JP¥35.32 in 1Q 2022). Revenue: JP¥834.0m (up 20% from 1Q 2022). Net income: JP¥64.0m (up 68% from 1Q 2022). Profit margin: 7.7% (up from 5.5% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 26% share price gain to JP¥2,767, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 8x in the Construction industry in Japan. Total loss to shareholders of 26% over the past three years. Announcement • Jun 01
MT Genex Corporation to Report Q1, 2023 Results on Aug 05, 2022 MT Genex Corporation announced that they will report Q1, 2023 results on Aug 05, 2022 Reported Earnings • May 17
Full year 2022 earnings released: EPS: JP¥197 (vs JP¥211 in FY 2021) Full year 2022 results: EPS: JP¥197 (down from JP¥211 in FY 2021). Revenue: JP¥2.97b (down 1.3% from FY 2021). Net income: JP¥212.0m (down 6.6% from FY 2021). Profit margin: 7.1% (down from 7.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Announcement • May 15
MT Genex Corporation, Annual General Meeting, Jun 23, 2022 MT Genex Corporation, Annual General Meeting, Jun 23, 2022. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Koji Nagano was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Apr 08
MT Genex Corporation to Report Fiscal Year 2022 Results on May 13, 2022 MT Genex Corporation announced that they will report fiscal year 2022 results on May 13, 2022 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥40.00 per share Eligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (3.1%). Reported Earnings • Feb 14
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: JP¥51.05 (down from JP¥60.41 in 3Q 2021). Revenue: JP¥712.0m (down 16% from 3Q 2021). Net income: JP¥55.0m (down 15% from 3Q 2021). Profit margin: 7.7% (in line with 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 11
Second quarter 2022 earnings released: EPS JP¥75.21 (vs JP¥36.25 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥816.0m (up 50% from 2Q 2021). Net income: JP¥81.0m (up 108% from 2Q 2021). Profit margin: 9.9% (up from 7.2% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 45% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 09
First quarter 2022 earnings released: EPS JP¥35.30 (vs JP¥39.03 in 1Q 2021) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: JP¥695.0m (up 9.6% from 1Q 2021). Net income: JP¥38.0m (down 9.5% from 1Q 2021). Profit margin: 5.5% (down from 6.6% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings. Reported Earnings • May 16
Full year 2021 earnings released: EPS JP¥211 (vs JP¥322 in FY 2020) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥3.01b (down 7.8% from FY 2020). Net income: JP¥227.0m (down 34% from FY 2020). Profit margin: 7.5% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥40.00 per share Eligible shareholders must have bought the stock before 30 March 2021. Payment date: 24 June 2021. Trailing yield: 1.4%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (2.6%). Announcement • Mar 04
MT Genex Corporation to Report Fiscal Year 2021 Results on May 12, 2021 MT Genex Corporation announced that they will report fiscal year 2021 results on May 12, 2021 Reported Earnings • Feb 14
Third quarter 2021 earnings released: EPS JP¥60.31 (vs JP¥28.81 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥848.0m (up 51% from 3Q 2020). Net income: JP¥65.0m (up 110% from 3Q 2020). Profit margin: 7.7% (up from 5.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Announcement • Jan 08
MT Genex Corporation to Report Q3, 2021 Results on Feb 12, 2021 MT Genex Corporation announced that they will report Q3, 2021 results on Feb 12, 2021 Reported Earnings • Nov 11
Second quarter 2021 earnings released: EPS JP¥36.25 The company reported a soft second quarter result with weaker earnings and revenues, although profit margins were improved. Second quarter 2021 results: Revenue: JP¥544.0m (down 13% from 2Q 2020). Net income: JP¥39.0m (down 11% from 2Q 2020). Profit margin: 7.2% (up from 7.1% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 19
Market pulls back on stock over the past week After last week's 18% share price decline to JP¥3,200, the stock is trading at a trailing P/E ratio of 10.7x, down from the previous P/E ratio of 13x. This compares to an average P/E of 8x in the Construction industry in Japan. Total returns to shareholders over the past three years are 55%. Announcement • Oct 10
MT Genex Corporation to Report Q2, 2021 Results on Nov 09, 2020 MT Genex Corporation announced that they will report Q2, 2021 results on Nov 09, 2020 Announcement • Sep 29
MT Genex Corporation (JASDAQ:9820) agreed to acquire Chiyoda Me Service Corporation from Takashi Sawai and other shareholders. MT Genex Corporation (JASDAQ:9820) agreed to acquire Chiyoda Me Service Corporation from Takashi Sawai and other shareholders on September 28, 2020. MT Genex will make Chiyoda Me Service a consolidated subsidiary. As at April 30, 2020, Chiyoda Me Service had net assets of JPY 161 million and total assets of JPY 469 million. For the year ended April 30, 2020, Chiyoda Me Service had revenues of JPY 738 million, operating income of JPY 10 million and net income of JPY 4 million. The share transfer execution date is October 1, 2020. Announcement • Jun 28
MT Genex Corporation to Report Q1, 2021 Results on Aug 07, 2020 MT Genex Corporation announced that they will report Q1, 2021 results on Aug 07, 2020